Key facts
- Notable investors include Sanara Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Vflow
- ·The full record, as it builds
Funding rounds
No funding rounds for Vflow are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vflow
Developer of vascular stents intended for brain endovascular treatments. The company's stent is specifically designed for the treatment of cerebral venous insufficiency, which helps to un-sheath and re-sheath multiple times until the stent location is satisfactory, enabling medical practitioners to handle surgical procedures with care and accuracy.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2021
- Website
- vflow21.com/
- Ownership
- Privately Held (backing)
Vflow doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vflow shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vflow in its N-PORT filings yet. We sweep new filings monthly.